Louisiana State Employees Retirement System increased its holdings in Bath & Body Works, Inc. (NYSE:BBWI - Free Report) by 740.5% during the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund owned 105,900 shares of the company's stock after purchasing an additional 93,300 shares during the period. Louisiana State Employees Retirement System's holdings in Bath & Body Works were worth $4,106,000 at the end of the most recent quarter.
Other large investors also recently bought and sold shares of the company. Fifth Third Wealth Advisors LLC boosted its stake in shares of Bath & Body Works by 4.9% during the fourth quarter. Fifth Third Wealth Advisors LLC now owns 6,982 shares of the company's stock valued at $271,000 after purchasing an additional 324 shares during the period. TD Private Client Wealth LLC boosted its stake in shares of Bath & Body Works by 24.2% during the third quarter. TD Private Client Wealth LLC now owns 1,697 shares of the company's stock valued at $54,000 after purchasing an additional 331 shares during the period. UMB Bank n.a. boosted its stake in shares of Bath & Body Works by 58.8% during the fourth quarter. UMB Bank n.a. now owns 905 shares of the company's stock valued at $35,000 after purchasing an additional 335 shares during the period. Avior Wealth Management LLC boosted its stake in shares of Bath & Body Works by 30.3% during the fourth quarter. Avior Wealth Management LLC now owns 1,950 shares of the company's stock valued at $76,000 after purchasing an additional 453 shares during the period. Finally, Golden State Wealth Management LLC purchased a new stake in shares of Bath & Body Works during the fourth quarter valued at $26,000. Institutional investors own 95.14% of the company's stock.
Analyst Ratings Changes
BBWI has been the subject of a number of recent analyst reports. Argus reissued a "hold" rating on shares of Bath & Body Works in a research note on Friday, January 10th. Deutsche Bank Aktiengesellschaft upped their price objective on shares of Bath & Body Works from $51.00 to $52.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. Piper Sandler upped their price objective on shares of Bath & Body Works from $36.00 to $39.00 and gave the stock a "neutral" rating in a research note on Monday, January 6th. TD Cowen upped their price objective on shares of Bath & Body Works from $42.00 to $48.00 and gave the stock a "buy" rating in a research note on Thursday, December 12th. Finally, Wells Fargo & Company raised shares of Bath & Body Works from an "equal weight" rating to an "overweight" rating and upped their price objective for the stock from $42.00 to $48.00 in a research note on Friday, January 10th. One equities research analyst has rated the stock with a sell rating, six have assigned a hold rating and ten have given a buy rating to the company's stock. Based on data from MarketBeat.com, Bath & Body Works has a consensus rating of "Moderate Buy" and a consensus price target of $43.19.
Check Out Our Latest Analysis on Bath & Body Works
Bath & Body Works Price Performance
Bath & Body Works stock traded up $0.07 during trading hours on Friday, reaching $36.50. The stock had a trading volume of 1,835,171 shares, compared to its average volume of 2,762,514. Bath & Body Works, Inc. has a 52 week low of $26.20 and a 52 week high of $52.99. The company has a market cap of $7.91 billion, a price-to-earnings ratio of 8.90, a PEG ratio of 0.90 and a beta of 1.83. The business's 50 day moving average price is $37.63 and its 200-day moving average price is $33.66.
Bath & Body Works (NYSE:BBWI - Get Free Report) last posted its quarterly earnings data on Monday, November 25th. The company reported $0.49 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.46 by $0.03. Bath & Body Works had a net margin of 12.43% and a negative return on equity of 44.03%. The firm had revenue of $1.61 billion for the quarter, compared to the consensus estimate of $1.58 billion. During the same quarter in the prior year, the company posted $0.48 earnings per share. The company's revenue for the quarter was up 3.1% compared to the same quarter last year. On average, sell-side analysts forecast that Bath & Body Works, Inc. will post 3.26 EPS for the current fiscal year.
Bath & Body Works Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Friday, March 7th. Stockholders of record on Friday, February 21st will be issued a dividend of $0.20 per share. The ex-dividend date of this dividend is Friday, February 21st. This represents a $0.80 annualized dividend and a dividend yield of 2.19%. Bath & Body Works's dividend payout ratio (DPR) is currently 19.51%.
About Bath & Body Works
(
Free Report)
Bath & Body Works, Inc is a specialty retailers and home to America's Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.
See Also

Before you consider Bath & Body Works, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bath & Body Works wasn't on the list.
While Bath & Body Works currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.